Piper Jaffray Downgrades Pacific Biosciences of California (PACB) to Neutral
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.15 --0%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray downgraded Pacific Biosciences of California (NASDAQ: PACB) from Overweight to Neutral, price target cut from $12 to $7.
For more ratings news on Pacific Biosciences of California click here and for the rating history of Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.56 yesterday.
For more ratings news on Pacific Biosciences of California click here and for the rating history of Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
